956 studies found for:    "Esophageal cancer"
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
3 Recruiting SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Stereotactic Body Radiation Therapy;   Thymalfasin
Interventions: Radiation: Stereotactic Body Radiation Therapy;   Drug: Thymalfasin
4 Completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Recurrent Esophageal Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage III Esophageal Cancer;   Stage IV Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
5 Recruiting Pembrolizumab With Locally Delivered Radiation Therapy for the Initial Treatment of Metastatic Esophageal Cancers
Conditions: Esophageal Neoplasms;   Esophageal Cancer;   Cancer of the Esophagus
Interventions: Drug: Pembrolizumab;   Radiation: Brachytherapy;   Procedure: Endoscopic biopsy;   Procedure: Ultrasound-guided biopsy;   Procedure: Computed tomography-guided biopsy;   Procedure: Peripheral blood collection
6 Recruiting Genetic and Environmental Risk Factors Related to Esophageal Cancer
Condition: Esophageal Cancer
Intervention:
7 Recruiting Esophageal Cancer Genetics Studies
Conditions: Esophageal Cancer;   Gastric (Cardia, Body) Cancer
Intervention:
8 Unknown  Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: carboplatin;   Drug: fluorouracil;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
9 Active, not recruiting PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: Oxaliplatin;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Drug: Carboplatin;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Radiation: Radiation Therapy
10 Completed Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Intervention: Procedure: quality-of-life assessment
11 Unknown  Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: Paclitaxel;   Drug: Capecitabine
12 Completed Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Drug: bryostatin 1;   Drug: paclitaxel
13 Unknown  S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: tegafur-gimeracil-oteracil potassium;   Other: cytology specimen collection procedure;   Procedure: endoscopic biopsy
14 Completed Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
Conditions: Barretts Esophagus;   Esophageal Cancer
Intervention: Procedure: Cryospray Ablation
15 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
16 Completed Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Procedure: conventional surgery
17 Terminated Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
Condition: Esophageal Cancer
Interventions: Drug: gefitinib;   Procedure: conventional surgery;   Procedure: enzyme inhibitor therapy;   Procedure: neoadjuvant therapy;   Procedure: protein tyrosine kinase inhibitor therapy;   Procedure: surgery
18 Active, not recruiting Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: paclitaxel;   Radiation: radiation therapy
19 Completed Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel
Condition: Esophageal Cancer
Interventions: Drug: alvocidib;   Drug: paclitaxel
20 Terminated
Has Results
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Conditions: Esophageal Cancer;   Adenocarcinoma of the Esophagus;   Squamous Cell Carcinoma
Interventions: Drug: OncoGel (Paclitaxel gel);   Drug: cisplatin;   Drug: 5-FU;   Radiation: radiation therapy;   Procedure: esophageal resection

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years